Professor Osagie K. Obasogie’s ‘Legacies of Eugenics’ Project
By Gwyneth Shaw,
Berkeley Law
| 08. 23. 2024
In this episode, host Gwyneth Shaw talks to Professor Osagie K. Obasogie, a professor of law and bioethics and the only UC Berkeley faculty member to hold an appointment at both our law school and our School of Public Health(opens in a new tab), including the Joint Medical Program(opens in a new tab) with UC San Francisco. As a sociologist of law and medicine, Obasogie’s research combines doctrinal scholarship with empirical methods and novel theoretical approaches to understand the ways race is central to how the institutions of law and medicine operate.
He’s the author of Blinded By Sight: Seeing Race Through the Eyes of the Blind and co-editor of Beyond Bioethics: Toward a New Biopolitics, and his scholarship has been published in top law reviews as well as major medical and science journals. Obasogie is an elected member of the National Academy of Medicine and won a Guggenheim Fellowship in 2022.
Recently, he organized and wrote the opening essay for a major project published in the Los Angeles Review of Books, “Legacies of Eugenics...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...